Treatment patterns and outcomes in over 2200 newly diagnosed multiple myeloma patients: supporting bortezomib-lenalidomide-dexamethasone as a preferred regimen in the absence of anti-CD38 antibodies

• Authors: JUNGOVÁ Alexandra; ŠTORK Martin; ŠPIČKA Ivan; RADOCHA Jakub; MINAŘÍK Jiří; PAVLICEK Petr; MIHÁLYOVÁ Jana; POUR Luděk; STRAUB Jan; MAISNAR Vladimír; PIKA Tomas; DEKOJOVA Tereza; SOUKUP Jan; POPKOVA Tereza; MENŠÍKOVÁ Klára; SEDLÁK Frantisek; POSPISKOVA Jana; BOICHUK Ivanna; KRHOVSKA Petra; STOPKA Tomáš; JINDRA Pavel; JELÍNEK Tomáš; KNECHTOVÁ Zdenka; CAPOUNOVA Vladimira; LATAL Vojtech; MURONOVA Ludmila; HEINDORFER Adriana; ULLRYCHOVÁ Jana; SYKORA Michal; KESSLER Petr; HÁJEK Roman
• Year of publication: 2026
• Type: Peer-reviewed scientific article
• Magazine / Source: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
• Doi: https://doi.org/10.1016/j.clml.2025.10.022.